Medical Glossary

Tumor Burden — Total Amount of Cancer in the Body

Tumor burden, sometimes called tumor load, refers to the total volume, weight, or number of cancer cells present in a person's body. Measuring tumor burden helps oncologists assess how advanced a cancer is, monitor how well a therapy is working, and determine the risk of treatment-related complications.

3 min readLast reviewed August 1, 2026Medically reviewed by: GetOnco Medical Review Team

In simple terms

You can think of tumor burden as the overall quantity of cancer your body is carrying at a given moment. It accounts for both the physical size of any main lumps and the number of secondary spots that may have spread elsewhere. A lower tumor burden generally means less cancer to eradicate, while a higher burden means the disease is more widespread. Tracking this quantity helps doctors see whether treatments are successfully shrinking the disease.

Key takeaways

  • Tumor burden measures the overall amount, size, and spread of cancer throughout the body.
  • It is monitored over time to determine whether a cancer is shrinking, stable, or growing.
  • High tumor burden can increase the risk of certain therapeutic side effects.
  • Techniques like liquid biopsies and ctDNA are increasingly used to track microscopic burden.

Definition

Tumor burden is an objective clinical metric describing the extent of disease within an individual. It encompasses the physical dimensions of the primary tumor alongside the number, size, and distribution of any metastatic lesions present in lymph nodes or distant organs.

In hematologic malignancies, such as leukaemia or multiple myeloma, tumor burden relates to the percentage of malignant cells in the bone marrow or circulating in the bloodstream. Evaluating tumor burden over time provides vital prognostic insight into biological aggressiveness and therapeutic responsiveness.

Why it matters

Knowing your tumor burden helps your clinical team choose the safest and most effective therapy. A high tumor burden may require aggressive systemic therapies or careful monitoring to prevent acute complications like tumor lysis syndrome. Following your tumor burden throughout treatment provides immediate clarity on whether the disease is responding, remaining stable, or progressing, allowing timely adjustments.

Related biomarkers and tests

Solid tumor burden is evaluated using serial CT, MRI, or PET scans adhering to standardised criteria such as RECIST. Circulating tumor burden is assessed via blood tests measuring protein biomarkers (such as PSA, CA-125, or CEA) or modern circulating tumor DNA (ctDNA) assays.

Related cancers

The concept applies across oncology, including solid tumors like colorectal, lung, breast, and melanoma, as well as hematologic cancers such as chronic lymphocytic leukaemia, acute leukaemias, multiple myeloma, and non-Hodgkin lymphomas.

Related treatments

A substantial tumor burden may influence drug dosing, prompt the use of debulking surgery or radiation, or dictate prophylactic hydration before chemotherapy. In immunotherapy, tumor burden can impact how effectively the immune system can control the malignancy.

Frequently asked questions

Does a high tumor burden mean a cancer is incurable?

Not necessarily. While a higher tumor burden often signifies more extensive disease, many high-burden cancers respond exceptionally well to modern therapies like targeted drugs, chemotherapy, or immunotherapy, leading to substantial reduction or remission.

How do doctors know if my tumor burden is decreasing?

Doctors track tumor burden by comparing baseline scans (such as CT or PET scans) with follow-up scans taken during treatment, or by tracking falling levels of specific tumor markers in your routine blood tests.

What is the difference between tumor burden and cancer stage?

Cancer stage describes where the cancer is located and how far it has spread based on fixed criteria. Tumor burden measures the actual physical volume or total amount of cancer cells present at a specific point in time.

References

  1. 1.NCI Dictionary of Cancer Terms: Tumor BurdenNational Cancer Institute
  2. 2.Understanding Cancer Staging and VolumeCancer.Net (ASCO)
  3. 3.ESMO Clinical Practice Guidelines: OverviewEuropean Society for Medical Oncology
GetOnco

Ask GetOnco AI

Get personalised answers about Tumor Burden — Total Amount of Cancer in the Body from your AI cancer care coordinator.

GetOnco AI provides educational information and never replaces advice from your medical team.

Explore related topics

All Medical Glossary articlesExplore other categories
Medically reviewed by:GetOnco Medical Review Team — Oncology-trained clinicians and medical editors

Last reviewed August 1, 2026

Medical disclaimer

Educational information only. GetOnco is software, not a medical provider, and does not diagnose disease or recommend treatments. Always discuss your situation with qualified healthcare professionals.